Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase.
about
Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other DiseasesMelatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.Targeting reactive oxygen species in development and progression of pancreatic cancer.Chromatin remodeling factor lymphoid-specific helicase inhibits ferroptosis through lipid metabolic genes in lung cancer progression.DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.
P2860
Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Selective killing of K-ras-tra ...... by targeting NAD(P)H oxidase.
@ast
Selective killing of K-ras-tra ...... by targeting NAD(P)H oxidase.
@en
type
label
Selective killing of K-ras-tra ...... by targeting NAD(P)H oxidase.
@ast
Selective killing of K-ras-tra ...... by targeting NAD(P)H oxidase.
@en
prefLabel
Selective killing of K-ras-tra ...... by targeting NAD(P)H oxidase.
@ast
Selective killing of K-ras-tra ...... by targeting NAD(P)H oxidase.
@en
P2093
P2860
P1476
Selective killing of K-ras-tra ...... s by targeting NAD(P)H oxidase
@en
P2093
Peng Huang
Wen-Hua Lu
Yi-Chen Sun
P2860
P2888
P304
P356
10.1186/S40880-015-0012-Z
P50
P577
2015-04-08T00:00:00Z
P5875
P6179
1044101978